Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial (Q42955589)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 July 2010
edit
Language Label Description Also known as
English
Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial
scientific article published on 21 July 2010

    Statements

    Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial (English)
    Jörn Peter Sieb
    Wolfgang Köhler
    21 July 2010
    781-784

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit